pembrolizumab
merck
['pembro', 'melanoma']
novel il-2 shows activity in previously treated #melanoma patients, alone and with pembro. exciting news about #immunotherapy in #asco2022 
Medical oncologist, @lemelbaum institute for immuno-oncology. Treating patients with #Melanoma, interested in #Immunotherapy and clinical trials